Stocks and Investing
Stocks and Investing
Mon, November 13, 2023
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
Raghuram Selvaraju Maintained (ANVS) at Strong Buy with Decreased Target to $30 on, Nov 13th, 2023
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Annovis Bio, Inc." (ANVS) at Strong Buy with Decreased Target from $40 to $30 on, Nov 13th, 2023.
Raghuram has made no other calls on ANVS in the last 4 months.
There is 1 other peer that has a rating on ANVS. Out of the 1 peers that are also analyzing ANVS, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Tyler Bussian of "Brookline Capital" Initiated at Strong Buy and Held Target at $35 on, Friday, November 10th, 2023
Contributing Sources